neuropsychopharmacology

A to Z

neuropsychopharmacology

This shows two heads with a psychedelic background

Featured Neuroscience Open Neuroscience Articles Psychology

·May 30, 2019·4 min read

‘Ecstasy’ shows promise for post-traumatic stress treatment

MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.

This image shows the anatomy to the VTA with the striatum, nucleus accumbens and substantia nigra labelled.

Featured Psychology

·July 21, 2015·3 min read

A New Target For Depression Treatment

Researchers have identified a potential new target to treat recurring depression.

This image shows the location of the prefrontal cortex.

Featured Psychology

·March 5, 2015·4 min read

Abnormal Brain Rhythms Tied to Problems with Thinking in Schizophrenia

Using a unique mouse model, researchers show cognitive deficits associated with schizophrenia may be reversible.

Featured Psychology

·March 15, 2018·5 min read

ADHD Drug Increases Glutamate and Positive Emotion in Healthy People

A new study reveals a psychostimulant prescribed for ADHD increases glutamate in the brains of healthy people, resulting in more positive emotions.

Image shows a girl holding her head in her hands.

Featured Psychology

·January 3, 2018·5 min read

ADHD Increases STI Risk, But Medications May Help Reduce It

A new study reveals ADHD increases the risk of sexually transmitted infections in adolescents threefold compared to the general population. However, the use of ADHD medications reduces the risk of STIs in males by up to 41%.

Image shows a woman sitting at a table and two transparent men.

Featured Psychology

·February 3, 2016·4 min read

An Alternative Treatment Target For Schizophrenia

A new study suggests that dysregulation in the way two G protein-coupled receptors talk to each other may be responsible for some symptoms of schizophrenia.

Featured Neuroscience Psychology

·November 1, 2018·4 min read

Anti-Convulsant Drug Reduces Major Depression Symptoms

Ezogabine, an FDA approved anti-convulsant, appears to significantly reduce symptoms in those with major depressive disorder.

This shows the outline of a woman's head

Featured Neuroscience Psychology

·March 5, 2021·3 min read

Anti-Hyperlipidemia Drug Improves Brain Connectivity Schizophrenia

Fenofibrate, a drug developed to control cholesterol, alleviated brain and behavioral abnormalities in mouse models of schizophrenia.

Featured Psychology

·December 12, 2016·3 min read

Antidepressant Effects of Ketamine Can Be Separated From Potential Side Effects

Ketamine may improve brain functions involved in mood regulation, researchers report.

Featured Neurology Open Neuroscience Articles

·December 20, 2017·5 min read

Antidepressant May Help Combat the Course of Multiple Sclerosis

A new Nature Communications study reports the antidepressant Clomipramine may relieve symptoms of primary progressive multiple sclerosis.

Featured Neuroscience Open Neuroscience Articles Psychology

·November 13, 2020·6 min read

Antidepressant May Prevent Severe COVID-19, Trial Suggests

A new small scale study reveals the antidepressant fluvoxamine may be a new tool in the fight against COVID-19. Researchers report fluvoxamine reduced the severity of coronavirus symptoms and hospitalizations.